A home workout plan for the oldest old — can it stave off frailty?

NCT ID NCT07731529

Not yet recruiting Disease control Sponsor: Federal University of Rio Grande do Sul Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether a personalized, home-based exercise program called Vivifrail can improve physical function, muscle health, and thinking skills in adults aged 90 and older. Participants are split into three groups: exercising twice a week, three times a week, or a control group. Researchers measure changes in balance, walking speed, and chair-stand ability over 12 and 24 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a home-based multicomponent exercise program called Vivifrail, tailored to each person's abilities
What this could lead to: If it works, this could point toward a simple, home-based exercise plan to help the oldest adults stay mobile, strong, and sharp.
What could go wrong: This is a small, early-stage trial with only 54 participants, so results may not apply to everyone. The exercises require a caregiver's support, which may limit who can take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGING COGNITIVE DECLINE FRAILTY

Contacts and locations

Locations

Escola de Educação Física, Fisioterapia e Dança (ESEFID/UFRGS) - and participants' homes

Porto Alegre, Rio Grande do Sul, 90690-200, Brazil
Hospital de Clínicas de Porto Alegre (HCPA) - Geriatrics outpatient clinic

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.